Mt. Margolis et al., HEMOTHORAX AFTER LUPRON THERAPY OF A PATIENT WITH PLEURAL ENDOMETRIOSIS - A CASE-REPORT AND LITERATURE-REVIEW, International journal of fertility and menopausal studies, 41(1), 1996, pp. 53-55
Background-Pulmonary endometrial implants, although uncommon, have bee
n well described in the literature. Symptoms occur with menses and may
include recurrent pleuritic chest pain, pneumothorax, hemoptysis, or
hemothorax. Exacerbation of pulmonary symptoms by Lupron therapy has n
ot been previously described. Case Report-A 38-year-old African-Americ
an female with known endometriosis but no history of pulmonary disease
was evaluated for a 2-year history of severe dysmenorrhea. A trial of
hormonal suppression was unsuccessful, and she was offered Lupron the
rapy. Three weeks after its initiation, and shortly after the onset of
menses, she came to the emergency room with pleuritic chest pain and
shortness of breath and was found to have a right-sided hemopneumothor
ax. Thoracentesis treatment was successful in eliminating this symptom
. Conclusion-Although pulmonary endometriosis is rare, physicians shou
ld be aware that Lupron therapy can exacerbate pulmonary symptoms duri
ng the initial phase of therapy.